Peer-influenced content. Sources you trust. No registration required. This is HCN.

Pharmacy Practice NewsNew Iron Deficiency Guideline Reshapes Oral Dosing and Infusion Protocols

✅ Guideline Update

Consensus recommendations address persistent variation in oral dosing, IV infusion protocols, pregnancy management, reaction classification, and follow-up after iron treatment.


Clinical Considerations

  • Oral iron more than once daily increases gastrointestinal effects without meaningfully improving absorption.
  • Guidance favors total-dose IV infusion and discourages routine test doses or premedication.
  • Pregnancy recommendations distinguish first-trimester oral therapy from later-trimester IV treatment.
  • Reassessment should occur no sooner than four weeks after IV administration.

Practice Applications

  • Review oral dosing frequency and elemental iron content.
  • Verify the implicated formulation before accepting an iron-allergy label.
  • Assess treatment tolerance, access, cost, and pregnancy stage.
  • Establish laboratory follow-up and evaluate the deficiency’s underlying cause.
The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form